Accel Wealth Management Novartis Ag Transaction History

Accel Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$80.03 - $92.81 $1,840 - $2,134	-23 Reduced 4.12%	535 $49,000
Q2 2022 Aug 03, 2022	SELL	$80.52 - $93.75 $2,013 - $2,343	-25 Reduced 4.29%	558 $47,000
Q1 2022 Apr 29, 2022	BUY	$80.11 - $90.62 $160 - $181	2 Added 0.34%	583 $51,000
Q4 2021 Jan 18, 2022	BUY	$79.7 - $88.13 $1,833 - $2,026	23 Added 4.12%	581 $51,000
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $1,880 - $2,188	-23 Reduced 3.96%	558 $46,000
Q2 2021 Aug 03, 2021	SELL	$85.24 - $94.15 $1,022 - $1,129	-12 Reduced 2.02%	581 $53,000
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $7,431 - $8,763	-89 Reduced 13.05%	593 $51,000
Q4 2020 Jan 27, 2021	BUY	$78.07 - $94.43 $53,243 - $64,401	682 New	682 $64,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Accel Wealth Management with notifications on news.